20.04.2007 Genentech Extends Stock Repurchase Program

19.04.2007 Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer

19.04.2007 Cell Therapeutics, Inc. Closes $37.2 Million Offering

18.04.2007 Pharmion Corporation to Announce First Quarter 2007 Financial Results

18.04.2007 Bard to Host Earnings Conference Call on April 24, 2007

18.04.2007 Bard Declares Quarterly Dividend

18.04.2007 Dyax Corp. to Host First Quarter 2007 Earnings Call and Webcast

18.04.2007 2007 Recipients of Amgen Award for Science Teaching Excellence Announced

17.04.2007 CTI Settles Qui Tam Suit with Government, Suit Against Medicare Reimbursement Advisor to Recover Damages Filed

17.04.2007 Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema

16.04.2007 Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting

13.04.2007 MediGene AG Initiates Clinical Phase II Trial of EndoTAGTM-1 for the Treatment of Hormone Receptor Negative Breast Cancer

05.04.2007 JDRF To Collaborate with MediGene AG to Develop an Antigen-Specific Immunotherapeutic for Type I Diabetes

04.04.2007 Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study

04.04.2007 Notice of annual general meeting

02.04.2007 Cambridge Consultants provides Expert’s Report for the UK's first pharmaceutical listing in 2007 - Neuropharm Group plc